Shizuoka, Japan

Hiroaki Matsushita



Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hiroaki Matsushita - Innovator in Pharmaceutical Composition

Introduction

Hiroaki Matsushita is a prominent inventor based in Shizuoka, Japan, well-known for his contributions to the field of pharmaceuticals. With two patents to his name, he has made significant strides in developing novel compositions aimed at improving health outcomes for individuals suffering from atopic dermatitis.

Latest Patents

Matsushita's latest patents focus on a pharmaceutical composition for the prevention and/or treatment of atopic dermatitis. These compositions feature an IL-31 antagonist as an active ingredient. In these non-limiting embodiments, the IL-31 antagonist is to be administered repeatedly in equal amounts, adhering to specific dosing intervals for subjects who have or may potentially have atopic dermatitis. The dosages range from 0.1 to 1000 mg per body, taken over durations from one day to twelve weeks, with preferred intervals identified as two weeks, four weeks, or eight weeks.

Career Highlights

Hiroaki Matsushita is associated with Chugai Seiyaku Kabushiki Kaisha, a company recognized for its innovative contributions to the pharmaceutical industry. His dedication to research and development has resulted in impactful inventions that demonstrate a commitment to addressing complex health concerns.

Collaborations

Throughout his career, Matsushita has collaborated with talented coworkers such as Akihisa Kaneko and Yuki Iwayanagi. These partnerships have facilitated a dynamic exchange of ideas and expertise, allowing for enhanced innovation in the pharmaceutical realm.

Conclusion

Hiroaki Matsushita exemplifies the spirit of innovation with his focused efforts in the field of pharmaceuticals, particularly concerning atopic dermatitis treatments. His patents not only reflect his ingenuity but also hold the potential to significantly benefit patients struggling with this condition. As he continues his work at Chugai Seiyaku Kabushiki Kaisha, the future looks promising for further advancements resulting from his research and collaborative efforts.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…